We're headed to AMP 2019 in Baltimore, MD, will you be attending?
September Newsletter
We're headed to ASHG!

We're headed to AMP 2019!
Baltimore, MD |  November 7-9, 2019
Booth #2856

We hope you will stop by our booth #2856 for a demo or one of our Innovation Spotlight Talks at Stage 1:

Thursday, Nov 7th – 2:15pm – 2:45pm
State of the Art Clinical Copy Number Variant Analysis in Next-Gen Sequencing Data: Gene Panels, Whole Exome, Whole Genome

Saturday, Nov 9th – 10:00am – 10:30am
Clinical Variant Analysis: Applying the AMP & ACMG Guidelines in the Clinical Practice

See our full demo schedule, or request a one-on-one meeting with our team here.

Reflecting on ASHG 2019

Reflecting on ASHG 2019
By Andreas Scherer, Ph.D.
President & CEO

As our team returns from another successful ASHG conference, I would like to reflect on the great memories, connections, and future plans that were made at this meeting. First, I will start by thanking everyone involved with the superb planning and execution of the conference. We are thankful to have this opportunity to connect with our customers, partners, and friends... Read More

VSWarehouse Upgrade: Somatic Variant Analysis via VSClinical AMP Guidelines

VSWarehouse Upgrade: Somatic Variant Analysis via VSClinical AMP Guidelines
By Darby Kammeraad
Field Application Scientist Manager

Join us for our upcoming webcast, Nov. 6 at 12pm EST, as we delve into VSWarehouse with a focus on our new capability of storing somatic variant projects and catalogs built for the AMP Guidelines within VSClinical. Previous webcasts have gone into great detail on the features and processing of somatic variants following the automated AMP Guidelines in VSClinical... Read More

VSWarehouse Upgrade: Somatic Variant Analysis via VSClinical AMP Guidelines

Oncogenicity Scoring in VSClinical
By Nathan Fortier, Ph.D.
Director of Research

Before examining the clinical evidence associated with a specific mutation, a clinician must establish that the variant is likely to be a driver mutation which generates functional changes that enhance tumor cell proliferation. Our recent blog series “Following the AMP Guidelines with VSClinical” briefly mentioned how the oncogenicity scoring system in VSClinical could be used to automate and assist the... Read More

CEO Corner
New eBook: Clinical Variant Analysis for Cancer

We are back from another successful ASHG 2019 conference! We had an incredible amount of interest in our new VSClinical capabilities, in particular, our new AMP Guidelines workflow. In just a few weeks we will be heading to Baltimore for the AMP 2019 meeting. We are excited to present this new capability to an audience entirely focused on cancer. If you are planning on attending, I invite you to join us for our Innovation Spotlight Talks where we will be presenting the details of our AMP guideline solution and CNV calling capabilities for NGS tests.. I look forward to seeing everyone there!

Upcoming Webcast

VSWarehouse Upgrade: Somatic Variant Analysis via VSClinical AMP Guidelines  
November 6, 2019 | 12:00 PM Eastern

Join us for our upcoming webcast as we delve into VSWarehouse with a focus on our new capability of storing somatic variant projects and catalogs built for the AMP Guidelines within VSClinical. We will also be demonstrating how VSWarehouse efficiently navigated through stored variants via the VSWarehouse Browser.

Register
Customer Publications

October is Breast Cancer Awareness month, therefore, we dedicated our Customer Publication feature to those customers who have published a piece on the disease citing Golden Helix software. To highlight just a couple:

"Complex Landscape of Germline Variants in Brazilian Patients With Hereditary and Early Onset Breast Cancer" - Dirce Carraro & Colleagues, A.C. Camarago Cancer Center, Brazil / Published in Frontiers of Genetics (2018)

"Characterization of Familial Breast Cancer in Saudi Arabia" - Ashraf Dallol & Colleagues, King Abdulaziz University / Published in BMC Genomics (2015)

Read the full list of featured breast cancer articles published over the years on our blog!

About Golden Helix

Golden Helix has been delivering industry-leading bioinformatics solutions for the advancement of life science research and translational medicine for over 20 years with 1,000s of users around the world. Their innovative technologies and analytic services empower scientists and healthcare professionals at all levels to derive meaning from the rapidly increasing volumes of genomic data produced from NGS sequencers and microarrays. With their solutions, hundreds of the world's top hospitals, testing labs, pharmaceutical, biotech, and academic research organizations can harness the full potential of genomics to identify the cause of disease, improve the efficacy and safety of drugs, develop genomic diagnostics, and advance the quest for personalized medicine.